Clinical Trial Update: Effects of Ticagrelor Versus Prasugrel on Coronary Microcirculation in Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the PROtecting MICROcirculation During Coronary Angioplasty (PROMICRO)-3 Randomised Study [Phase 4]

View source ↗

Summary

Phase 4 randomized study comparing ticagrelor versus prasugrel on coronary microcirculation in patients undergoing elective PCI (PROMICRO-3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Germano Di Sciascio | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED